Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer

被引：1

作者：

Laukhtina, Ekaterina ^{[1
,2
]}

Shariat, Shahrokh F. ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

机构：

[1] Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria

[2] Sechenov Univ, Inst Urol & Reprod Hlth, Moscow, Russia

[3] Karl Landsteiner Inst Urol & Androl, Vienna, Austria

[4] Weill Cornell Med Coll, Dept Urol, New York, NY USA

[5] Univ Texas Southwestern, Dept Urol, Dallas, TX USA

[6] Charles Univ Prague, Fac Med 2, Dept Urol, Prague, Czech Republic

[7] Al Ahliyya Amman Univ, Hourani Ctr Appl Sci Res, Amman, Jordan

[8] Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria

来源：

EUROPEAN UROLOGY | 2022年 / 82卷 / 02期

关键词：

CHEMOTHERAPY;

D O I：

10.1016/j.eururo.2022.04.010

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：242 / 243

页数：2

共 50 条

[1] Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer
Rose, Tracy L.
Harrison, Michael R.
Deal, Allison M.
Ramalingam, Sundhar
Whang, Young E.
Brower, Blaine
Dunn, Mary
Osterman, Chelsea K.
Heiling, Hillary M.
Bjurlin, Marc A.
Smith, Angela B.
Nielsen, Matthew E.
Tan, Hung-Jui
Wallen, Eric
Woods, Michael E.
George, Daniel
Zhang, Tian
Drier, Anthony
Kim, William Y.
Milowsky, Matthew I.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28) : 3140 - +
[2] Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC).
Rose, Tracy L.
Harrison, Michael Roger
Deal, Allison Mary
Osterman, Chelsea K.
Ramalingam, Sundhar
Whang, Young E.
Brower, Blaine Y.
Bjurlin, Marc
Smith, Angela B.
Nielsen, Matthew E.
Tan, Hung-Jui
Wallen, Eric M.
George, Daniel J.
Zhang, Tian
Drier, Anthony
Kim, William Y.
Milowsky, Matthew, I
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
[3] Re: Ekaterina Laukhtina, Shahrokh F. Shariat. Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer. Eur Urol. 2022;82:242-3
Takahashi, Takeshi
EUROPEAN UROLOGY, 2022, 82 (04) : E107 - E108
[4] Phase II trial of neoadjuvant nivolumab with cisplatin and gemcitabine in muscle-invasive bladder cancer patients undergoing radical cystectomy.
Gupta, Shilpa
Agarwal, Neeraj
Konety, Badrinath R.
Weight, Christopher J.
Thyagarajan, Bharat
Murugan, Paari J.
Koopmeiners, Joseph S.
Sonpavde, Guru
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
[5] Neoadjuvant Therapy before radical Cystectomy for muscle-invasive Bladder Cancer Phase Ib/II Study for Evaluating the neoadjuvant Combination Therapy of Vinflunine with Cisplatin followed by a radical Cystectomy in Patients with muscle-invasive Bladder Cancer (JaNEO) - Study AB 50/15 of the AUO
Rexer, H.
Merseburger, A.
UROLOGE, 2016, 55 (10): : 1366 - 1367
[6] Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine plus Cisplatin in Patients with Muscle-Invasive Bladder Cancer
Chang, Sam S.
JOURNAL OF UROLOGY, 2020, 203 (04): : 659 - 660
[7] Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer
Voskuilen, Charlotte S.
van der Heijden, Michiel S.
van Rhijn, Basw. G.
EUROPEAN UROLOGY, 2019, 76 (06) : 870 - 871
[8] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
Kaneko, Gou
Kikuchi, Eiji
Matsumoto, Kazuhiro
Obata, Jun
Nakamura, So
Miyajima, Akira
Oya, Mototsugu
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
[9] Camrelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
Xing, N.
Han, S.
Jiang, J.
Xu, W.
Shi, B.
Ping, H.
Ji, Z.
Ma, Q.
Wang, H.
Chen, S.
Wang, W.
Fan, X.
Zhou, Q.
Zhang, W.
ANNALS OF ONCOLOGY, 2021, 32 : S714 - S714
[10] Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer
Iyer, Gopa
Balar, Arjun V.
Milowsky, Matthew I.
Bochner, Bernard H.
Dalbagni, Guido
Donat, S. Machele
Herr, Harry W.
Huang, William C.
Taneja, Samir S.
Woods, Michael
Ostrovnaya, Irina
Al-Ahmadie, Hikmat
Arcila, Maria E.
Riches, Jamie C.
Meier, Andreas
Bourque, Caitlin
Shady, Maha
Won, Helen
Rose, Tracy L.
Kim, William Y.
Kania, Brooke E.
Boyd, Mariel E.
Cipolla, Catharine K.
Regazzi, Ashley M.
Delbeau, Daniela
McCoy, Asia S.
Vargas, Hebert Alberto
Berger, Michael F.
Solit, David B.
Rosenberg, Jonathan E.
Bajorin, Dean F.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1949 - +

← 1 2 3 4 5 →